UC Ophthalmology Receives Grant to Fight Blindness
The University of Cincinnati has received a $110,000 grant from Research to Prevent Blindness (RPB) to continue the study of sight-robbing diseases.
The grant was made to the UC Department of Ophthalmology to support research into the causes, treatment and prevention of blinding disease. To date, the organization has awarded grants to UCs medical college totaling nearly $2 million.
"In recent years, RPB support has enabled our faculty and trainees to make important advances in evaluation and management of dry eye disease, corneal scarring and intraocular cancer
particularly choroidal melanoma, retinoblastoma and intraocular lymphoma, says James Augsburger, MD, professor and department chair, who will direct the research grant.
Established in 1960, RPB is a volunteer organization supported by private and corporate donors and has awarded grants to over 50 scientific institutions in the U.S.
"We are extremely grateful to RPB for its generous financial support, says Augsburger, adding that funding from the RPB is of vital importance to ongoing clinical and laboratory research.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.